<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Personalized medicine (PM) is currently a hot topic in the professional world </plain></SENT>
<SENT sid="1" pm="."><plain>It is often called the medicine of the future and has already achieved resounding success in the area of targeted therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Nevertheless, integration of the concepts of PM into routine clinical practice is slow </plain></SENT>
<SENT sid="3" pm="."><plain>This review is intended to give an overview of current and potential applications of PM in <z:hpo ids='HP_0002664'>oncology</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>PM could soon play a decisive role, especially in screening </plain></SENT>
<SENT sid="5" pm="."><plain>The relevance of PM in screening was examined in the case of four common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (<z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, and <z:hpo ids='HP_0012125'>prostate cancer</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>A literature search was performed </plain></SENT>
<SENT sid="7" pm="."><plain>This showed that biomarkers in particular play a crucial role in screening </plain></SENT>
<SENT sid="8" pm="."><plain>In summary, it can be emphasized that there are already numerous known promising biomarkers in malignant disease </plain></SENT>
<SENT sid="9" pm="."><plain>This results in several possibilities for individualizing and revolutionizing screening </plain></SENT>
</text></document>